期刊文献+

黄芪注射液对系统性红斑狼疮外周血白细胞和免疫功能的影响 被引量:5

Effects of Radix Astragali Injection on Leukopenia and Immune Function of Patients with Systemic Lupus Erythematosus
下载PDF
导出
摘要 目的:探讨黄芪注射液在治疗系统性红斑狼疮中对外周血白细胞和免疫功能的影响。方法:选择外周血白细胞总数低于正常值的系统性红斑狼疮患者79例;随机分为常规治疗组(应用常量皮质类固醇和免疫抑制剂)和黄芪治疗组(在常规治疗的基础上加用黄芪注射液);观察和比较两组患者在治疗前后外周血白细胞、免疫球蛋白(IgG、IgA、IgM)和补体(C3、C4)的变化。结果:两组患者的外周血白细胞计数、免疫球蛋白(IgG、IgA、IgM)和补体(C3、C4)在治疗后均有不同程度的提高(P<0.05),但两组患者治疗后外周血象和免疫学指标的比较表明黄芪治疗组疗效显著优于常规治疗组(P<0.05)。结论:黄芪注射液在一定程度提高了应用皮质类固醇和免疫抑制剂治疗系统性红斑狼疮患者的疗效,可以作为提高系统性红斑狼疮疗效的重要辅助治疗措施。 Objective: To explore the effects of Radix Astragali injection on leukopenia and immune function of patients with systemic lupus erytbematosus (SLE). Methods: A total of 79 SLE patients with lower leukocyte count were randomly assigned into routine . trestment group ( treated with routine dose of corticosteroids and immunosuppressants), and Radix Astragali group ( treated with routine dose of corticosteroids and immunosuppressants and Radix Astragali injection). Then this study tested and compared the change of leukocyte number, immune globulin (IgG, IgA and IgM) and complement ( C3, CA) in peripheral blood before and after the treatments. Results: The number of peripheral blood leukocytes, immune globulin and complement increased in both groups after the treatments ( P 〈0 0.05). However, the treatment effects in the Radix Astragali group pmved much better than that in the routine treatment group ( P 〈 0.05 ). Conclusion : Radix Astragali injection can enhance the curative effect of corticosteroids and immunosuppressants in the treatment of SLE. It may be a valuable assistant method to enhance the efficacy of SLE treatment.
出处 《四川中医》 北大核心 2007年第11期20-21,共2页 Journal of Sichuan of Traditional Chinese Medicine
关键词 系统性红斑狼疮 黄芪注射液 外周血白细胞 免疫球蛋白 补体 systemic lupus erythematosus, Radix Astragali injection, peripheral blood leukocytes, immune globulin, complement
  • 相关文献

参考文献10

二级参考文献45

  • 1苏永忠,谢建英,刘元生.以血细胞异常为首发的系统性红斑狼疮临床调查研究[J].临床误诊误治,2004,17(7):490-492. 被引量:3
  • 2徐建华,徐胜前,王芬,刘爽,孙桂华.系统性红斑狼疮血清免疫学指标与疾病活动性的关系[J].安徽医学,1996,17(6):13-14. 被引量:2
  • 3蒋明 田新平.系统性红斑狼疮的临床.风湿病学[M].北京:科学技术出版社,1996.1037-1038.
  • 4黄次波 朱楚汉.系统性红斑狼疮.现代自身免疫病学[M].北京:人民军医出版社,1996.173-174.
  • 5卢君健 蒋明.免疫缺陷病.风湿病学[M].北京:科学技术出版社,1996.1291-1302.
  • 6Vitali C, Bencivelli W, Isenberg DA. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research [J]. Clin Exrp Rheumatol ,1992,10: 541-547.
  • 7Quismorio FP. Hematologic and Lymphoid Abnormalities in Systemic Lupus Erythematosus. In: Wallace DJ, Hahn BH.Dubois Lupus Erythematosus [M]. 5th ed. Baltimore:Willams & Wikins , 1997. 793.
  • 8Bombardier C, Gladman DD,Urowitz MB. Derivation of the sLEDAI: a disease activity index for lupus patients[J].Arthritis Rheuma , 1992,35: 630-640.
  • 9Liang MH, Socher SA, Larson MG. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus[J]. J Rheumatol , 1989, 16:1395-1396.
  • 10Caramaschi P, Melchiorri S, Biasi D, et al . Thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus. Clinical diagnosis and therapeutic strategies[J]. Recenti Prog Med , 2000,91(10):525-531.

共引文献87

同被引文献117

引证文献5

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部